Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications
- Publication date
- 1 January 2006
- Publisher
- 'Centro de Investigaciones y Publicaciones Farmaceuticas (CIPF)'